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httcense.Abstract Purpose: To evaluate the ability of interval spaced sessions of transcatheter partial sple-
nic artery embolization (PSE) to avoid the potential post procedure major complications, in portal
hypertension patients with hypersplenism.
Material and methods: The study included 50 patients (39 male and 11 females). All patients had
liver cirrhosis and portal hypertension with hypersplenism and hyperactive bone marrow. All
patients underwent PSE in two sessions separated at least by 1 month interval. Immediate, short
and intermediate term follow-up for 1 year were done.
Results: We had no post procedure mortality. None of the patients developed septic shock, splenic
abscess or needed emergency surgery. Ten of our patients developed subcapsular collections which
were treated conservatively. All of our patients showed signiﬁcant increase in the thrombocyte
count after the ﬁrst session which becomes remarkable after the second session and remained at
appropriate levels during the follow up period.
Conclusion: PSE using two (interval-spaced) sessions with careful pre- and post procedure medica-
tions and care; is really effective non surgical minimally invasive procedure in avoiding the potential
post procedure complications while achieving remarkable hematologic response on controlling
hypersplenism in cirrhotic patients with portal hypertension.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.(A.A. Nassef).
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Portal hypertension has four well-known complications: bleed-
ing esophageal varices, ascites, encephalopathy, and hyper-
splenism. Hypersplenism is a dangerous complication which
may lead to serious bleeding tendency due to thrombocytopenia
and recurrent infections due to leucopenia (1). Splenectomy, thegyptian Society of Radiology and Nuclear Medicine.
.04.004
532 A.A. Nassef et al.traditional deﬁnitive treatment even with good preoperative
preparation and careful surgery may be hazardous in patients
with poor liver function as it carries high mortality rate and risk
of major complications (2).
For the last 20 years, partial splenic embolization has been
used to treat patients with hypersplenism effectively; markedly
improving the platelet and leucocytic counts, relieving throm-
bocytopenia and resolving cytopenia (2–4).
However, partial splenic embolization is often associated
with considerable high risk of complications which might be
severe in many occasions. The real problem is that in severely
decompensated patients with late liver disease and remarkable
thrombocytopenia there is no chance to surgically interfere
with those severe complications such as splenic abscess or total
splenic necrosis which may lead to procedure related deaths
(2,3,5,6).
Hematologic response correlates with the amount of the
infarcted splenic tissue after partial splenic embolization.
Almost all of the interventionists attempt to achieve infarction
between 50% and 70% of the splenic mass to get good thera-
peutic hematologic response and alleviate hypersplenism
(5,7,8).
The larger the amount of the infarcted splenic tissue, the
earlier and greater will be the hematologic response; yet, much
more severe the complications will be, as the severity of com-
plications correlates with the amount of the infarcted splenic
mass (5,7,8).
A lesser extent of infarction allows reduced sequestration
and destruction of the blood elements and preservation of
the ante grade ﬂow within the splenic vein reducing the possi-
bility of thrombosis and minimizes the possibility of complica-
tions; however it does not ensure the desirable therapeutic
response and the long term efﬁcacy (8).
2. Aim of the work
The aim of this study was to achieve the maximum permissible
splenic tissue infarction with the least possible complications
by performing partial splenic embolization in two separate
consecutive sessions.
3. Patients and methods
3.1. Patients
In the period between September 2007 and May 2011, 50 pa-
tients (39 men and 11 women), their age ranging from 35 to
58 years (median age of 43 years) with hypersplenism second-
ary to liver cirrhosis and portal hypertension underwent partial
splenic artery embolization (PSE) with the aim to eliminate
hypersplenism. The exclusion criteria were patients with hypo-
cellular bone marrow, patients with known collagen vascular
or autoimmune disorders, and patients with ischemic heart dis-
ease, hypertension, renal failure, or malignant disease.
Patients were referred from the inpatient or outpatient
clinic of tropical medicine department, Kasr Al Ainy hospital.
The Child-Pugh classiﬁcations of these patients were Child A
in 26 patients, Child B in 14 patients and Child C in 10
patients. All patients were selected to have thrombocytopenia,platelet counts of 30–60,000/mm3 (mean 42800/mm3), with or
without leucopenia; leucocytic count 1500–3800/mm3 (mean
2360/mm3). Bone marrow aspiration was done to all patients
and proved hyper cellular.
After written consent, all patients were subjected to a thor-
ough history taking with special stress on bleeding tendency,
variceal hemorrhage, repeated infections, and previous blood
transfusion. Thorough physical examination was done to eval-
uate the state of the liver, spleen, ascites, or manifestations of
liver cell failure. Laboratory investigations including complete
blood picture (CBC), complete liver function, coagulation pro-
ﬁle and serum creatinine were carried out.
3.2. Pre-procedure preparation
PSE, like splenectomy, can theoretically increase the risk of
infection by encapsulated organisms including Streptococcus
pneumoniae, haemophilus inﬂuenza type B, and Neisseria
meningitides. Consideration should be given to vaccines such
as 23-valent pneumococcal polysaccharide vaccine (PPV-23).
It was given 2 weeks before PSE. All patients should be given
proper information to reduce infectious complications.
The day before examination the patients were admitted to
hospital, all of their laboratory data were revised and they
started antibiotics as follows: cephalosporin 1 g IV every
12 h and metronidazole 500 mg every 8 h.
Six units of fresh frozen plasma were given in every patient
in the night before examination.
A baseline platelet count was obtained in the morning of
the examination.
3.3. Technique
All of the patients underwent two sessions of PSE separated by
at least 1 month interval. The common femoral artery was
punctured and catheterized with placement of 5F introducer
sheath, and then the splenic artery was selectively catheterized
by 5F Cobra catheter (Imager- Boston Scientiﬁc, USA). Diag-
nostic angiograms were obtained to deﬁne the arterial anatom-
ical distribution of the intra-splenic branches and demonstrate
the splenic parenchymal blush (splenogram). The Cobra cath-
eter is advanced distally as much as we can near the splenic
hilum. If this was not feasible by the cobra catheter owing to
the marked tortuosity of the hypertrophied splenic artery a
coaxial microcatheter (Renegade HI-FLO microcatheter, Bos-
ton Scientiﬁc, USA) was advanced through the mother cobra
catheter to reach the splenic hilum or a desired intra-splenic
branch. Embolization was then done by administration of
355–500 lm poly vinyl alcohol particles (Contour- PVA,
Target therapeutics, Boston Scientiﬁc USA).
In the ﬁrst session, administration of the particles was con-
tinued and control angiograms were obtained till splenograms
demonstrate defective parenchymal patches (defective spleno-
gram) between 30% and 40% (Figs. 1b, 3a and 5b) of the
initial splenogram (Figs. 1a and 5a) denoting the rate of
splenic infarction, thus avoiding major devitalization. At this
point the examination was stopped the sheath was removed
and manual vascular compression was applied for at least
30 min.
Fig. 1 Selective splenic angiography delayed phase showing splenic parenchymal blush (splenogram): (a) Before embolization showing
homogeneous complete blush, (b) After completion of the 1st session showing defective splenogram with multiple parenchymal ﬁlling
defects (arrows) counting for overall 30–40% splenic infarction, (c) After the 2nd session further splenic parenchymal blush defects are
noted with evident decrease of its density giving an overall 70–80% splenic infarction.
Fig. 2 Unenhanced CT scan for the upper abdomen showing splenic infarctions: (a) 1 week after the 1st session showing hypodense
splenic focal defects representing infarctions, (b) 1 week after the 2nd session showing further extensive splenic infarctions with reduced
size of the spleen notably its anterior pole from previous infarction.
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The patients were hospitalized for the procedure day and the
next 5 days where they continued on the same dose of IV
antibiotics, also all of them were given analgesics and antipy-
retics like oral paracetamol every 6 h and fever chart monitor
was followed up. Fifteen patients needed stronger analgesia.
pethidine 1.5 mg/kg body weight was given IV every 6 h in
the second and third days after the procedure beside the
paracetamol.
The patients were discharged after their hospital stay on
oral 3rd generation cephalosporin or quinolones 500 mg/12 h
for 1 week.
In the second session the same steps were done but admin-
istration of PVA particles was continued till 70–80% defective
splenograms were obtained (Figs. 1c, 3b and 5c). The same
post procedure care applied.3.5. Follow up
Post procedure follow up US was performed on the day of the
examination and repeated 1 week later before discharge and
then every 1 month in the ﬁrst 3 months and every 3 months
during the 1 year follow up.
Platelet count was done 1 week after the procedure before
discharge of the patients and 1 week later.
All of our patients were followed every 1 month in the ﬁrst
3 months and every 3 months during the 1 year follow-up period
inoutpatient clinic, a followupplatelet countwas done and revised.
Unenhanced CT scan of the upper abdomen was done after
1 week from the procedure before discharge in all patients to
evaluate the extent of devitalization and infarctions as well as
to detect any complications (Figs. 2, 4and 6). In 10 patients with
subcapsular collections follow up CT after 1, 2 and 3 months
were done if needed to evaluate the progress of the condition.
Fig. 4 (a) and (b) Unenhanced CT scan 1 week after the 2nd session showing extensive splenic infarction counting for about 80%.
Fig. 3 Selective splenic angiography delayed phase showing splenic parenchymal blush (splenogram): (a) After completion of the 1st
session showing defective splenogram with multiple parenchymal ﬁlling defects (arrows) counting for overall 30–40% splenic infarction.
(b) After the 2nd session showing remarkable splenic infarction with evident decrease and loss of the splenic parenchymal blush as well as
large defects giving an 80% splenic infarction.
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Moderate fever up to 38.5 C, lasting 2 to 5 days was noticed
almost in all patients. All of our patients complained of mod-
erate pain in the left hypochondrial which was easily controlled
with light analgesics. Thirty percent of our patients had severe
pain that warranted medications other than analgesics in the
second and third days after the procedure.
Mild pleural effusions with or without minimal basal atelec-
tases were noted in 20% of our patients They were noted on
the follow up CT scan and were not followed by any clinical
signs of chest infection.
Ten of our patients developed subcapsular collections
(Fig. 7) which were treated conservatively and needed no inter-
ventions (Fig. 8).
None of our patients developed or gave signs of splenic
abscess formation.We had no procedure related mortality in the immediate
post procedure period or during the 1 year follow up period.
The platelet counts rose signiﬁcantly after one week from the
ﬁrst session and it was still rising in the second week. By the end
of one month 40% of the patients reached the normal values.
After 1 week from the second session all of our patients
(100%) reached the normal platelet count values. The platelet
count at 6 months and one year follow-up was within normal
values in all of our patients with slight decline in three patients
yet still within the normal values.
Leucocytic counts also rose signiﬁcantly after 2 weeks of
PSE compared to counts before PSE. At follow up, leucocytic
counts were within the normal range and were signiﬁcantly
higher than before PSE for all patients despite the decline
noted after 1 month and 1 year follow up counts.
Coagulation studies, serum bilirubin, and serum albumin
values were not altered signiﬁcantly by PSE. Serum alanine
Fig. 5 Selective splenic angiography delayed phase showing splenic parenchymal blush (splenogram): (a) Before embolization showing
homogeneous complete blush. (b) After completion of the 1st session showing defective splenogram with multiple parenchymal ﬁlling
defects (arrows)) counting for overall 30–40% splenic infarction. (c) After the 2nd session further splenic parenchymal blush defects are
noted with evident decrease of its density giving an overall 70–80% splenic infarction.
Fig. 6 Unenhanced CT scan 1 week after the 2nd session
showing extensive splenic infarction counting for about 80%.
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elevated immediately after PSE, and returned to normal levels
after 2 months (Table 1).5. Discussion
Partial splenic embolization has been used in the last three dec-
ades to treat patients with hypersplenism effectively; markedly
improving the platelet and leucocytic count and relieving
thrombocytopenia (2,3,8).
Being minimally invasive, it is presumably precluding the
risk of surgery and splenectomy complications; however, par-
tial splenic embolization is often associated with considerable
high risk of complications in most series which might be severe
in many occasions (3,5,6). The real problem is that in severelydecompensated patients with late liver disease and remarkable
thrombocytopenia there is no chance to surgically interfere
with those severe complications such as splenic abscess or total
splenic necrosis which may lead to procedure related mortality.
Hematologic response and the severity of complications
correlate with the amount of the infarcted splenic tissue after
partial splenic embolization (8). This was clearly demonstrated
in Zhu K et al., study in which they were classifying their
patients into three groups according to the splenic infarction
rate after partial splenic artery embolization as: group (A)
more than 70%, group (B) 50–70%, and group C less than
50% with no signiﬁcant differences among the sex, age, splenic
volume, Child-Pugh class, varices and peripheral blood count
before PSE. After PSE they reported signiﬁcant differences in
the leucocytic and platelet counts among the three groups;
where in group A and B the counts remained signiﬁcantly
higher from 2 weeks up to 5 years and even much higher in
group A, while in group C the improvement only lasted for
6 months (5). Concurrently, they reported severe complica-
tions in half (50%) of patients in group A population, 8.8%
in group B, while in group C they reported no (0%) severe
complication. Based on this and on the general acceptance
by most of the interventionists that infarction between 50%
and 70% of the splenic mass is needed to get good therapeutic
hematologic response and alleviate hypersplenism (7–9); we
performed partial splenic embolization for all of our patients
in this study in two separate consecutive sessions spaced by
at least 1 month interval. We aimed to achieve between 30%
and 40% splenic tissue infarction of the splenic mass after
the ﬁrst session to reach 70–80% after completion of the sec-
ond session of the procedure. Our aim was to achieve such
large amount of splenic tissue infarction to get a desirable
good hematologic response with the least possible complica-
tions. By using this technique we succeeded to have no severe
complications in our series; we had no short or intermediate
related procedure related mortality, we had no severe compli-
cations, splenic abscess formation or septic shock. Twenty per-
cent (20%) of our patients developed subcapsular collections
Fig. 8 Follow up unenhanced CT scan for the upper abdomen 1 month after the 1st session of PSE showing decreased size of the
subcapsular collection. The ascites is still seen.
Table 1 Clinical picture of patients before and after PSE.
Before
procedure
After one week from
2nd session
After one month from
2nd session
After one year from
2nd session
P value
Child-Pugh grading (A/B/C) 26/14/10 26/14/10 24/16/10 22/15/13
AST (IU/L) 47.3 ± 31.17 52.3 ± 25.66 61.7 ± 16.09 65.7 ± 15.7 > 0.05
ALT (IU/L) 61.6 ± 51.8 72.3 ± 41.2 76.4 ± 17.5 64.5 ± 13.9 > 0.05
Serum albumin (g/dL) 3.4 ± 0.5 3.3 ± 0.4 3.3 ± 0.5 2.9 ± 0.3 > 0.05
Total bilirubin (mg/dL) 1.2 ± 1.0 1.1 ± 0.5 1.2 ± 0.5 1.3 ± 0.5 > 0.05
Prothrombin time (%) 67.0 ± 18.1 63.4 ± 13.1 62.2 ± 12.1 55.4 ± 12.2 > 0.05
WBC/lL 3.1 (+0.7) 10.5 (+1.6) 7.6 (+1.7) 6.3 (+1.1) = 0.002*
Platelets/lL 48.762 (+16.5) 293.470 (+33.3) 251.230 (+23.5) 235.330 (+22.7) < 0001**
* Paired T test is used to measure signiﬁcant difference between before procedure and one week follow up.
** Paired T test is used to measure signiﬁcant difference between before procedure and 1 week and between 1 month and 1 year F.up.
Fig. 7 Unenhanced CT scan for the upper abdomen 1 week after the 2nd session of PSE showing splenic infarctions with subcapsular
collection along the anterolateral surface of the spleen. Also note mild ascites seen in the perisplenic space and right paracolic gutter which
was newly developed in this patient.
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interventions and subsided later during the follow up period
(Fig. 8).On targeting our goal of minimizing the potential post tech-
nique complication we planned a strict careful pre and post
procedure medications and care including 1 week hospital stay
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to reduce the risk of the serious splenic abscess.
Nevertheless, we encountered moderate complications as
we had two patients who showed a notable increase in the
amount of ascites and another one who newly developed
ascites after the procedure (Fig. 7), both (6%) are accepted
as moderate complications and responded to conservative
treatment by oral diuretics. The afore mentioned incidence of
ascites is almost the same in N’Kontchou et al. who reported
(6.25%) 2 out of 32patients who had ascites after PSE in their
study (3); but much less than Abdella et al. who reported 50%
of their patients to have either increase in the amount or newly
developed ascites (6).
Also we had mild complications in similar rates like most of
other studies; almost all of our patients developed moderate
fever up to 38.5 C and left hypochondrial pain which usually
lasted for 2 to 5 days and easily controlled with antipyretics
and light analgesics. Thirty percent of the patients complained
of severe pain in the left hypochondrial which needed medica-
tions other than paracetamol.
Mild pleural effusions with or without basal atelectases
were noted in 20% of the patients, they were detected in the
basal chest cuts obtained during the follow up abdominal
CT scans. None of them was complicated by chest infection.
On evaluating the hematologic response, the platelet count
rose signiﬁcantly after one week from the ﬁrst session and it
was still rising in the second week. By the end of one month
40% of the patients reached the normal values while the remin-
der 60% dose not reach the normal values. After 1 week from
the second session all of our patients (100%) reached the nor-
mal values and it was still rising two weeks after the treatment.
The platelet count at 6 months and one year follow-up was
within normal values in all of our patients with slight decline
in three patients yet still within the normal values.
6. Conclusion
Partial splenic artery embolization PSE using two interval-
spaced sessions with careful pre- and post proceduremedications and care; is a really effective non surgical min-
imally invasive procedure in avoiding the potential post pro-
cedure complications while achieving remarkable
hematologic response on controlling hypersplenism in cir-
rhotic patients with portal hypertension.References
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